MINI REVIEW article
Front. Endocrinol.
Sec. Diabetes: Molecular Mechanisms
This article is part of the Research TopicGenetic Mechanisms in Diabetes PathogenesisView all 14 articles
Scars of Oxidative Stress: Protein Carbonylation and Beta Cell Dysfunction in Diabetes
Provisionally accepted
- 1City of Hope Arthur Riggs Diabetes & Metabolism Research Institute, California, Duarte, United States
- 2University of Colorado Denver, Denver, United States
- 3University of Colorado Anschutz Medical Campus, Aurora, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Diabetes is characterized by a profound loss of functional β-cell mass, driven by mechanisms that are still not fully understood. A spectrum of stressors drives this loss, including oxidative stress (OS). Unlike most cells, β-cells express unusually low levels of key antioxidant enzymes, rendering them highly susceptible to OS. Protein carbonylation (PC), a major hallmark of OS, is an irreversible modification that can be generated by covalent addition of lipid peroxidation products known as "reactive lipid aldehydes" (RLAs) into proteins, resulting in protein inactivation, misfolding, aggregation, degradation and formation of neo-antigens. PC plays a critical role in the pathogenesis of various human diseases, including diabetes. Increased RLAs and PC are found in islets, plasma, red blood cells and adipose tissue in diabetic patients and in diabetic rodent models. Limited studies, including ours, have globally mapped carbonylated proteins in pancreatic islets and specifically in β-cells. Yet no one has explored which proteins undergo carbonylation in human islets in diabetes and whether their carbonylation contributes to the loss of functional β-cell mass in diabetes. Cells have three cellular lines of defense against accumulation of PC: antioxidant enzymes, phase I and II metabolic enzymes that detoxify RLAs, and degradation of carbonylated proteins by 20S proteasome and lysosome. Since genes encoding all three lines of defense are controlled by the antioxidant master regulator, NRF2, activating this factor might be more advantageous than using pharmacological carbonyl scavengers. Future studies should test whether NRF2 activation can effectively reduce PC and preserve functional β-cells in diabetes.
Keywords: Protein Carbonylation, beta-cells, Nrf2, Lipid Peroxidation, diabetes
Received: 11 Oct 2025; Accepted: 12 Nov 2025.
Copyright: © 2025 Ling, Schultz, Knight, Shearn and Baumel-Alterzon. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Sharon Baumel-Alterzon, salterzon@coh.org
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.